-
-
2.
公开(公告)号:JP2006513251A
公开(公告)日:2006-04-20
申请号:JP2004567452
申请日:2003-12-23
发明人: オニシウ,ダニエラ,カルメン , ダシュー,ジャン−ルイ,アンリ
IPC分类号: C07C31/24 , A61K31/047 , A61K31/121 , A61K31/194 , A61K31/20 , A61K31/23 , A61K31/235 , A61K31/255 , A61K31/275 , A61K31/337 , A61K31/341 , A61K31/351 , A61K31/41 , A61K31/4178 , A61K31/422 , A61K31/4365 , A61K31/661 , A61K31/664 , A61P1/04 , A61P1/18 , A61P3/00 , A61P3/04 , A61P3/06 , A61P3/10 , A61P7/02 , A61P9/00 , A61P9/12 , A61P13/12 , A61P15/10 , A61P17/00 , A61P19/02 , A61P19/06 , A61P21/00 , A61P25/16 , A61P25/28 , A61P27/02 , A61P29/00 , A61P31/04 , A61P35/00 , A61P43/00 , C07C31/20 , C07C31/22 , C07C33/26 , C07C35/21 , C07C47/19 , C07C47/27 , C07C47/36 , C07C59/11 , C07C59/245 , C07C59/285 , C07C59/29 , C07C59/46 , C07C59/48 , C07C59/54 , C07C62/02 , C07C62/06 , C07C65/17 , C07C69/675 , C07C69/732 , C07C69/74 , C07C69/757 , C07C261/04 , C07C309/08 , C07C309/24 , C07C309/25 , C07D213/80 , C07D233/78 , C07D233/84 , C07D233/86 , C07D257/04 , C07D261/12 , C07D305/12 , C07D307/32 , C07D309/10 , C07D309/12 , C07D309/30 , C07D309/40 , C07D405/12 , C07D495/04 , C07F9/09 , C07F9/117 , C07F9/24 , C07F9/44
CPC分类号: C07C31/27 , A61K31/191 , A61K31/194 , A61K31/20 , A61K31/23 , C07C31/20 , C07C31/22 , C07C31/24 , C07C33/26 , C07C47/19 , C07C47/34 , C07C59/01 , C07C59/105 , C07C59/11 , C07C59/245 , C07C59/285 , C07C59/29 , C07C59/46 , C07C59/48 , C07C59/54 , C07C61/12 , C07C62/02 , C07C62/06 , C07C65/17 , C07C69/003 , C07C69/017 , C07C69/675 , C07C69/757 , C07C255/00 , C07C309/08 , C07C309/24 , C07C309/25 , C07C2101/02 , C07C2101/04 , C07C2101/08 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07D213/80 , C07D257/04 , C07D261/08 , C07D261/12 , C07D305/12 , C07D307/33 , C07D309/10 , C07D309/12 , C07D309/30 , C07D405/12 , C07D495/04 , C07F9/093 , C07F9/094 , C07F9/11 , C07F9/117 , C07F9/12 , C07F9/2408 , C07F9/2416 , C07F9/242 , C07F9/2425 , C07F9/4423
摘要: 本発明は、新規ヒドロキシル化合物と、ヒドロキシル化合物を含む組成物と、限定されるものではないが、老化、アルツハイマー病、癌、心臓血管疾患、糖尿病性腎症、糖尿病性網膜症、糖代謝障害、異脂肪血症、異リポタンパク血症、高血圧、インポテンス、炎症、インシュリン抵抗性、胆汁からの脂質除去、肥満、胆汁からのオキシステロール除去、膵炎、パンクレアティタス、パーキンソン病、ペルオキシソーム増殖活性化受容体関連障害、胆汁からのリン脂質除去、腎疾患、敗血症、代謝症候群障害(例えば、X症候群)、および血栓障害などの様々な病気および状態を治療および予防するのに有用な方法とに関する。 本発明の化合物および方法は、患者のC反応性タンパク質の変調、または胆汁産生の促進にも用いることができる。 特定の実施形態では、本発明の化合物、組成物、および方法は、コレステロール低下薬および血糖降下薬などの他の療法剤との併用療法に有用である。
摘要翻译: 本发明涉及新的羟基化合物,包含羟基化合物的组合物和可用于治疗和预防各种疾病和病症例如但不限于老化,阿尔茨海默氏病,癌症,心血管疾病,糖尿病性肾病,糖尿病性视网膜病变, 葡萄糖代谢异常,血脂异常,脂蛋白血症,高血压,阳ence,炎症,胰岛素抵抗,胆汁中的脂质消除,肥胖,胆汁中的氧固醇消除,胰腺炎,胰腺炎,帕金森病,过氧化物酶体增殖物激活受体相关病症,磷脂消除 胆汁,肾脏疾病,败血症,代谢综合症(如X综合症),血栓形成障碍。 本发明的化合物和方法也可用于调节C反应蛋白或增强患者胆汁产生。 在某些实施方案中,本发明的化合物,组合物和方法可用于与其它治疗剂的组合治疗; 如低胆固醇血症和降血糖药。
-
公开(公告)号:JPH10265427A
公开(公告)日:1998-10-06
申请号:JP6819597
申请日:1997-03-21
申请人: SUMIKIN CHEM KK
发明人: TAKEDA KYOICHI , SATO TOSHIO
IPC分类号: C07C45/43 , C07C47/36 , C07C67/29 , C07C67/307 , C07C69/157
摘要: PROBLEM TO BE SOLVED: To produce 6hydroxy and 6-acyloxy-2-naphthoaldehyde inexpensively in high yield. SOLUTION: 2-Methyl-6naphthol is acetylated with acetic anhydride, the formed 6-acetyloxy-4naphthalene is allowed to react with a halogenating agent to form 6acetyloxy-2dihalogenomethylnaphthalene as an intermediate. This intermediate is hydrolyzed in the presence of hydrogen halide acid in a water- lower carboxylic acid mixed solvent to form 6-hydroxy-2-naphthoaldehyde, while is hydrolyzed in the presence of a lower carboxylic alkali salt in an amount of more than the equimolar amount to the halogen group in the intermediate to form 6-acetyloxy-2-naphthoaldehyde selectively in high yields in both cases.
-
公开(公告)号:JPH01501229A
公开(公告)日:1989-04-27
申请号:JP50695587
申请日:1987-11-12
IPC分类号: C07D319/06 , C07C45/00 , C07C47/36 , C07C47/37 , C07C47/575 , C07C67/00 , C07C405/00 , C07D319/08 , C07F7/18
-
公开(公告)号:JPS6434913A
公开(公告)日:1989-02-06
申请号:JP19016687
申请日:1987-07-31
申请人: MITSUBISHI CHEM IND
发明人: NISHINO CHIKAO , KOBAYASHI KOJI , TAMAO YOSHIKUNI , OYA JUNICHI
IPC分类号: A61K31/05 , A61K31/047 , A61K31/085 , A61K31/11 , A61K31/60 , A61P35/00 , C07C39/11 , C07C43/23 , C07C47/36 , C07C47/37 , C07C65/05 , C07C65/21
摘要: PURPOSE:To provide an antitumor agent containing compounds existing in sumac of Rhus family as active components and exhibiting excellent action to inhibit the proliferation of Hela cell. CONSTITUTION:The compound of formula (X is hydroxy or methoxy; Y is carboxyl, aldehyde, hydroxymethyl or methoxycarbonyl; R is 15-17C alkyl; when X is methoxy, Y is carboxyl or hydroxymethyl) existing in the leaf of sumac (a plant of Rhus family) is used as an active component and prepared in the form of a drug by conventional method using conventional drug carrier to obtain the objective agent. It can be used in the form of injection, instillation, capsule, etc., and the rate of administration of the compound to adult is 5-100 mg/kg-body weight for injection and 20-500mg/kg-body weight for oral administration. The compound of formula can be produced by cutting leaves of sumac into small pieces, extracting with a proper solvent and purifying the extract by column chromatography.
-
公开(公告)号:JPS62226937A
公开(公告)日:1987-10-05
申请号:JP6897886
申请日:1986-03-26
发明人: KITANO HISAO , TANIMOTO FUMIO
IPC分类号: C07D317/20 , C07C27/00 , C07C31/27 , C07C33/05 , C07C33/12 , C07C35/06 , C07C41/00 , C07C43/18 , C07C45/00 , C07C47/36 , C07C49/493 , C07C51/00 , C07C59/11 , C07C59/13 , C07C59/147 , C07C59/205 , C07C59/29 , C07C59/31 , C07C59/325 , C07C59/353 , C07C59/46 , C07C59/62 , C07C59/74 , C07C59/82 , C07C62/02 , C07C62/08 , C07C62/16 , C07C62/24 , C07C62/30 , C07C67/00 , C07C69/66 , C07C69/757 , C07D311/00 , C07D317/72
摘要: NEW MATERIAL:A compound of formula I (the bond containing dotted line is single or double bond; A and B are carbonyl-type O, OH, CH2OH, alkoxy, aldehyde, hydroxycarbonyl, alkoxycarbonyl, hydroxycarbonylmethyl or alkoxy carbonylmethyl; R1 is vinyl, ethylidene or ethyl). EXAMPLE:2- or 3-vinyl-4-(carbomethoxymethyl)cyclopentanone. USE:Raw material for synthetic polymer, raw material for biochemical drug and intermediate for organic syntheses. PREPARATION:For example, a compound of formula I wherein A is carbonyl- type O and B is alkoxycarbonylmethyl can be produced by reacting 5- or 6- vinyl-2-norbornanone of formula II in a solvent in the presence of a compound of formula III such as m-chloroperbenzoic acid, reacting the resultant compound of formula IV with CH3ONa, etc., in a solvent to obtain the compound of formula V and reacting the compound with chromic acid mixture in a solvent.
-
公开(公告)号:JPS5748933A
公开(公告)日:1982-03-20
申请号:JP12480380
申请日:1980-09-09
申请人: Sankyo Co Ltd
发明人: AMAMIYA SHIGEO , KOJIMA KOUICHI , SAKAI KIYOSHI
IPC分类号: C07D317/72 , C07C45/00 , C07C45/61 , C07C47/36 , C07C47/37 , C07C49/523 , C07C67/00
CPC分类号: Y02P20/55
摘要: PURPOSE: To prepare the titled compound useful as a synthetic intermediate of 9(O)-methanoprostacycline, etc., in a shortened production process, by the condensation reaction of diformylmethylcyclopentane derivative in the presence of a base or a base and a metal salt.
CONSTITUTION: The objective compound of formula II such as 3α-hydroxy-4β- formvl-7-oxobicyclo[3.3.0]octane, etc. is prepared by the condensation reaction of the compound of formula I (A is oxo or carbonyl-protecting group) such as 1-oxo- 3α,4α-diformyl-methylcyclopentane in a solvent such as acetonitrile in the presence of a base such as pyridine hydrochloride or a combination of the base and a metal salt such as zinc acetate, in an inert gas tream (e.g. N
2 ) at -10°C W about room temp. for 30minW10hr. The amount of by-product can be reduced by using a metal salt in combination with the base.
USE: A synthetic intermediate of 9(O)methanoprostacycline or its derivative effective as a remedy and preventive for thermobosis.
COPYRIGHT: (C)1982,JPO&Japio摘要翻译: 目的:通过二甲酰基甲基环戊烷衍生物在碱或碱和金属盐的存在下的缩合反应,缩短制备方法,制备作为9(O) - 甲醛前列环素等合成中间体的标题化合物。 构成:通过式I化合物(A是氧代或羰基保护基)的缩合反应制备式II的目标化合物,例如3α-羟基-4,4a-甲基-7-氧代双环[3.3.0]辛烷等 基团)如1-氧代-3α,4α-二甲酰基 - 甲基环戊烷在溶剂如乙腈中,在碱如吡啶盐酸盐或碱和金属盐如乙酸锌的组合的存在下,在惰性气体中 在-10摄氏度(例如N2) - 约室温 30min-10hr。 通过使用与碱组合的金属盐可以减少副产物的量。 用途:9(O)甲基前列腺素或其衍生物的合成中间体作为治疗和预防热病的有效方法。
-
公开(公告)号:JPWO2014203944A1
公开(公告)日:2017-02-23
申请号:JP2015522965
申请日:2014-06-18
申请人: 国立大学法人京都大学
CPC分类号: C07C45/72 , B01J31/1805 , B01J2231/342 , B01J2531/0266 , C07C311/09 , C07C311/21 , C07D207/12 , C07D211/42 , C07C47/36
摘要: 本発明は、アルドール反応触媒およびこの触媒を用いた、立体選択的環状βヒドロキシアルデヒド化合物の製造方法を提供することを課題とする。斯かる課題を解決するための手段として、一般式(I):[化1][式中、R1、R2、R3a、R4a、Ra、Rは、明細書中に定義されるとおりである。]で表されるビアリール型アルドール反応触媒を提供する。
摘要翻译: 本发明是用于醛醇缩合反应的催化剂和催化剂,以及提供用于制造立体选择性环状β羟基醛化合物的方法。 作为解决这种问题的手段,在通式(I):[化学式1]其中,R1,R2中,R 3a中,R 4a中,R a,R如说明书中所定义。 提供由表示的联芳基类醛醇缩合反应的催化剂。
-
公开(公告)号:JPH09500117A
公开(公告)日:1997-01-07
申请号:JP50383595
申请日:1994-07-07
IPC分类号: A61K31/59 , A61K31/045 , A61K31/075 , A61P17/00 , A61P19/10 , A61P29/00 , A61P35/00 , A61P43/00 , C07C35/22 , C07C35/27 , C07C43/188 , C07C45/28 , C07C47/192 , C07C47/198 , C07C47/347 , C07C47/36 , C07C47/37 , C07C49/242 , C07C49/517 , C07C49/523 , C07C49/687 , C07C49/743 , C07C49/755 , C07C57/26 , C07C59/01 , C07C61/13 , C07C69/18 , C07C69/21 , C07C69/757 , C07C255/47 , C07C401/00
-
公开(公告)号:JPH0480890B2
公开(公告)日:1992-12-21
申请号:JP14264183
申请日:1983-08-05
申请人: ICI PLC
IPC分类号: C07C43/315 , A61K31/045 , A61K31/11 , A61K31/12 , A61K31/13 , A61K31/185 , A61K31/21 , A61K31/445 , A61P31/12 , A61P35/00 , C07C27/00 , C07C35/44 , C07C41/00 , C07C45/00 , C07C47/36 , C07C47/46 , C07C49/513 , C07C49/747 , C07C51/00 , C07C65/105 , C07C65/15 , C07C65/30 , C07C65/32 , C07C67/00 , C07C68/00 , C07C68/02 , C07C69/96 , C07C213/00 , C07C215/70 , C07C219/18 , C07C223/06 , C07C225/22 , C07C227/00 , C07C227/16 , C07C227/18 , C07C227/20 , C07C229/02 , C07C229/06 , C07C229/08 , C07C241/00 , C07C247/14 , C07C271/22 , C07C301/00 , C07C303/22 , C07C303/28 , C07C309/28 , C07C309/63 , C07C309/65 , C07C309/73 , C07C309/74 , C07C309/77 , C07D211/46 , C07D295/14 , C07D295/15 , C07D303/14 , C07D317/72 , C07D319/08 , C07D493/08 , C07F7/18
-
-
-
-
-
-
-
-
-